Popular Articles
Grapefruit Benefits

Abbott Initiates Trial Of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes From SPIRIT Family Of Trials
Abbott (NYSE: ABT) announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company"s next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System, currently an investigational device, for the treatment of coronary artery disease. Results from SPIRIT PRIME will be used to support the regulatory filing for XIENCE PRIME in the United States. The first patient was enrolled into the SPIRIT PRIME clinical trial at Hillcrest Medical Center in Tulsa, Okla., by Rajesh Chandwaney, M.D.
generic viagra online
Colorado Rural Co-Ops Provide Example For Health Care System Proposal
Rural utility co-ops in Colorado could provide an example of how a co-op would work nationally for health care, The Denver Post reports.
News of the day
Latest Replikins Data Predicts Continued High Level Of H1N1 (Swine Flu) Infectivity And Lethality
Biotech firm Replikins Ltd. released its analysis of the June and July genomic data that predicts the rates of infectivity and lethality of the H1N1 (Swine Flu) virus. The quantitative analysis shows continued elevated levels in the Replikin Counts* of both Infectivity and Lethality genes, which indicate that the end of the current outbreak is not yet in sight.
Mental Health

Spend More, Get Less? The Health Care 'Conundrum'

On NPR"s Fresh Air, New Yorker staff writer Atul Gawande spoke about his article on the high cost of health care in McAllen, Texas. He found that costs in McAllen were higher than in the rest of the country because doctors ordered more tests and treatments for their patients, which did not result in a better quality of care. Gawande told NPR that "the difficulty comes in the conflict between when medicine is a business versus when it"s a profession. In a grey-zone case, whether a patient should get that endoscopy for heartburn, whether you send them to have a particular operation like a carpal-tunnel release for carpal tunnel syndrome, we make more money, and there is a temptation and a strong incentive to do more rather than less. At the same time, if we"ve crossed the border to the point where over-treatment is actually producing harm, we now have to think about how to rein in that part of what we do, even though it can sometimes mean losing money." This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):